Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Did Tiger Cub Ian Murray Sell Out Of These Tech Stocks Just In Time?

Page 1 of 2

Ian P. Murray, the manager of Lanexa Global Management, is a respected hedge fund manager, and one of the many ‘Tiger Cubs’ who worked under Julian Robertson at Tiger Management in the past. According to his fund’s 13F filing with the U.S. Securities and Exchange Commission for the reporting period of June 30, his hedge fund has a public equity portfolio valued at $52.99 million, and is primarily invested in the technology sector. The fund’s 13F reveals that it had a total of 11 new purchases and sold out of 13 stocks during the second quarter. The performance of some of the stocks that it sold out of has shown that the hedge fund made a smart move, as some of these stocks have delivered disappointing second quarter results which have carried into the third quarter. In this article, we focus on three of the stocks in which the hedge fund sold out of, and analyze whether the timing was right to run far away from these tech stocks. The stocks are Yahoo! Inc. (NASDAQ:YHOO), Twitter Inc (NYSE:TWTR), and SanDisk Corporation (NASDAQ:SNDK).

Twitter Inc (NYSE:TWTR), Twitter profile, iPhone, Social network, Tweet, Media

Bloomua /

At Insider Monkey, we track hedge funds’ moves in order to identify actionable patterns and profit from them. Our research has shown that hedge funds’ large-cap stock picks historically underperformed the S&P 500 Total Return Index by an average of seven basis points per month between 1999 and 2012. On the other hand, the 15 most popular small-cap stocks among hedge funds outperformed the S&P 500 Index by an average of 95 basis points per month (read the details here). Since the official launch of our small-cap strategy in August 2012, it has performed just as predicted, returning over 123% and beating the market by more than 66 percentage points. We believe the data is clear: investors will be better off by focusing on small-cap stocks utilizing hedge fund expertise (while avoiding their high fees at the same time) rather than large-cap stocks.

Now let’s consider three of the stocks in which Lanexa Global Management sold out of completely, starting with Yahoo! Inc. (NASDAQ:YHOO). Going into the second quarter, the fund held a total of 50,000 shares of the company, with a market value of $2.22 million, having opened a new position in the stock during the first quarter. The hedge fund, however, decided to sell all of its shares in the stock during the second quarter. While there were hopes that the stock would perform well in the first quarter, it ended up disappointing, losing 12.03%. In the second quarter, Yahoo! Inc. (NASDAQ:YHOO) again lost 11.58%, and has lost 27.4% year-to-date. In its earnings results for the second quarter, the company disappointed as well, posting earnings per share of $0.16, missing the $0.18 in earnings per share expected by Wall Street analysts. Out of the hedge funds tracked by Insider Monkey, OZ Management, led by billionaire Daniel S. Och, had the largest position, holding 14.65 million shares valued at $650.88 million, after increasing its stake by 63%, a figure that represented 2.1% of its portfolio. Another billionaire fund that held a position in the stock going into the second quarter was D. E. Shaw, founded by David E. Shaw, which owned 12.43 million shares with a market value of $552.52 million.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!